Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLIGENIX, INC. Director's Dealing 2011

Dec 2, 2011

35119_dirs_2011-12-02_7e851bca-6c74-47a8-ade5-46c9565d9e93.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2011-12-01

Reporting Person: MYRIANTHOPOULOS EVAN (Director, Sr VP and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2011-12-01 Stock Option (Right to Buy) $0.032 A 1200000 Acquired 2021-11-30 Common Stock (1200000) Direct

Footnotes

F1: The option vests immediately as to 300,000 shares and vests as to the remainder of the shares on each three (3) month anniversary of December 1, 2011 at a rate of 75,000 shares per quarter thereafter. The exercise price of the option equals $0.032 per share, the market price of the Company's common stock as of the close of business on December 1, 2011.